Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment improved scalp health in women with early-stage hair loss.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Certain gut bacteria may protect against hair loss, while others may increase the risk.

A woman had a rare reaction to ear piercing that caused earlobe swelling, which was best treated by removing the piercing and not re-piercing.

Ruxolitinib can cause a delayed skin reaction on the nose.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Targeting macrophages may improve wound healing.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

We need safe, affordable drugs to fight coronaviruses effectively.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Satoyoshi syndrome is likely an autoimmune disease.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Understanding monosaccharide composition can improve the development of effective medicinal plant polysaccharides.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Understanding and treating alopecia areata improves patient care.